Company Search:
Advanced Search
Sponsored Links
Adcock Ingram Holdings Limited Company Snapshot
Adcock Ingram Holdings Limited is a healthcare company. The Company is a pharmaceutical manufacturer, which manufactures, markets and distributes a range of healthcare products, and supplies to both the private and public sectors of the market. The Company's segments include Over the Counter (OTC), Consumer, Prescription and Hospital. The OTC segment focuses primarily on brands sold predominantly in the pharmacy market. The Consumer segment is engaged in the fast moving consumer goods (FMCG) space. The Prescription segment markets products prescribed by medical practitioners. The Hospital segment operates as a supplier of hospital and critical care products, including intravenous solutions, blood collection products and renal dialysis systems. The Company's products include Allergex Non-Drowsy, Panado Paed Syrups, Probiflora Infant, Cepacol, Medi-Keel A, Adco-Acyclovir Topical Cream and Adco-Normospor Vaginal Cream.

Sales Analysis. During the year ended June of 2019, sales at Adcock Ingram Holdings Limited were 7.08 billion South African Rands (US$416.85 million). This is an increase of 8.2% versus 2018, when the company's sales were 6.54 billion South African Rands. This was the fifth consecutive year of sales increases at Adcock Ingram Holdings Limited (and since 2014, sales have increased a total of 47%). Sales of Prescription saw an increase that was more than double the company's growth rate: sales were up 22.4% in 2019, from 2.24 billion South African Rands to 2.74 billion South African Rands. Adcock Ingram Holdings Limited also saw significant increases in sales in Consumer (up 14.6% to 786.90 million South African Rands) . Not all segments of Adcock Ingram Holdings Limited experienced an increase in sales in 2019: sales of Corporate fell 76.0% to 48.40 million South African Rands. (However, this segment's sales were only a very small portion of the company's overall sales). Adcock Ingram Holdings Limited also experienced decreases in sales in Over the Counter (down 0.3% to 1.98 billion South African Rands) and Other - Shared Services (down 14.5% to 66.00 million South African Rands) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Adcock Ingram Holdings Limited
  Stock Performance Chart for Adcock Ingram Holdings Limited
  Stock Data: Recent Stock Performance:
  Current Price (7/3/2020): 48.00
(Figures in South African Rands)
1 Week 0.3%   13 Weeks -6.1%  
4 Weeks 5.0%   52 Weeks -20.8%  
Adcock Ingram Holdings Limited Key Data:
  Ticker: AIP Country: South Africa
  Exchanges: JNB Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2019 Sales 7,078,438,000
(Year Ending Jan 2020).
Employees: 2,610
  Currency: South African Rands Market Cap: 8,230,704,000
  Fiscal Yr Ends: June Shares Outstanding: 171,473,000
  Share Type: Ordinary Closely Held Shares: 117,435,527
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.